Immunoglobulin Demand Management

Trust Database Training

MAY 2008

http://www.intravenousimmunoglobulin.org/ 2

Objectives of training - aimed at data entry staff

• High level understanding of the need for the IVIg programme

• Identify the key stakeholders in the programme • Understand how to use the key functions of the database

• Understand your role in updating the database

• Establish who will support you going forward and how to get help

• Answer your questions

http://www.intravenousimmunoglobulin.org/ 3

Agenda

• IVIg Introduction and Background

• Proposed Process Overview

• Database Login and Registration Demo

• Database Panel and Infusion Demo

• Database Follow Up Demo

• End User Support Options

• Questions

http://www.intravenousimmunoglobulin.org/ 4

The DH kicked off the IVIg Demand management programme in 2006 to meet a number of historic challenges

•DEMAND MANAGEMENT OF IMMUNOGLOBULINS

Demand Management

Plan (promotion

of alternatives)

This programme aims to ensure that critical patients receive product and improve consistency of use of immunoglobulin

Clinical Guidelines

for appropriate

use of IVIg

Development of

database

Model Commissioning Policy (MCP)

Alternatives

Database online

MCP document

Guidelines online

Plan online

Alternativesdocument

http://www.intravenousimmunoglobulin.org/ 5

The National database will keep us informed on IVIg use

• Support the data management and reporting requirements of the Demand Management

Plan nationally agreed following extensive consultation with a wide range of stakeholders

• Capture immunoglobulin data from trusts nationally

• Inform a model of UK immunoglobulin use (along with PASA checking Pharmex)

• Enable better forecasting of likely use once the data history and quality builds up

• Estimate the requirements for alternatives to immunoglobulin such as plasma exchange

• Inform research and enable clinical trials regarding efficacy of immunoglobulin therapy

• Enable the formation of better contracts with immunoglobulin manufacturers

• Enable batch tracking

• Oxford Radcliff (Jenny Dorey)

• NLAG (Carrock Sewell)

• GKT (Stuart Richardson)

• UCLH (Evelyn Frank)

• Southend (Kevan Wind)

• Short term data collection• Enabled better understanding of what

the database should capture and effort• Use Pilot sites to support the exercise• Data in live system• Available to trusts who entered it

Pilot Sites Helped Development Data Collection Exercise

The purpose of the National Database is to:

http://www.intravenousimmunoglobulin.org/ 6

The IVIg database has a simple technical architecture that requires no end-user software and minimal training

Data EntryData Entry

Data ManagementData Management

Data ValidationData Validation

Portal/WebPortal/Web

Reporting & AnalysisReporting & AnalysisTechnical Support

MS Internet Explorer

only

Dendrite Propriety Solution

Dendrite Propriety Solution

NHS MDSAS

Team

Developers

Users

• DH commissioned National database for patients undergoing immunoglobulin therapy in the UK

• Dendrite developed the solution and will host it: keeping it up and running

• Anonymised data is owned by the DH

• NHS MDSAS will manage the vendor and end user support

• Database security - ID & password controlled entry managed by Trusts

• Efforts to align with national CfH standards have been successful

• Over the course of the next year, database will improve in terms of usage, data completeness and quality

• Increased automation, including bar coding, for the database is being planned

Outputs (To be confirmed by MDSAS):

• Monthly reports including compliance will be delivered

• Ad hoc data analysis

• Annual reports

Database OverviewDH and Trusts

http://www.intravenousimmunoglobulin.org/ 7

Agenda

• IVIg Introduction and Background

• Proposed Process Overview

• Database Login and Registration Demo

• Database Panel and Infusion Demo

• Database Follow Up Demo

• End User Support Options

• Questions

http://www.intravenousimmunoglobulin.org/ 8

Database entry is based on a simple process

Follow-up Follow-upInfusionDetails

InfusionDetails

PanelDecision

PanelDecisionRegistration Registration

• Demographics• Alternatives• Indication• Dose detail

• Approval• Efficacy

Tracking

• Prescriptions• Product detail• Returns• Infusion

Summary

• Follow-up• Efficacy

Tracking• Update

Registration

• Simple process based on paper-based form to track IVIg usage

• Different roles required to fill different parts of the form

• Responsibility of Trusts to assign responsibilities and process of getting the data into the database

• Some trusts are using data entry teams to manage data entry

• Further information on the process by reading the Demand Management Plan, Clinical Guidelines and Model Commissioning Policy, available on the website

http://www.intravenousimmunoglobulin.org/ 9

Agenda

• IVIg Introduction and Background

• Proposed Process Overview

• Database Login and Registration Demo

• Database Panel and Infusion Demo

• Database Follow Up Demo

• End User Support Options

• Questions

http://www.intravenousimmunoglobulin.org/ 10

1. Logging InLogin Screen

http://www.intravenousimmunoglobulin.org/ 11

1. Logging InWelcome Screen

http://www.intravenousimmunoglobulin.org/ 12

1. Logging InExport Data

http://www.intravenousimmunoglobulin.org/ 13

1. Logging InEnter Clinical Data

http://www.intravenousimmunoglobulin.org/ 14

2. RegistrationRegistration Data

http://www.intravenousimmunoglobulin.org/ 15

2. RegistrationAlternatives

http://www.intravenousimmunoglobulin.org/ 16

2. RegistrationIndication & Dose Information

http://www.intravenousimmunoglobulin.org/ 17

2. RegistrationDiagnosis

http://www.intravenousimmunoglobulin.org/ 18

2. RegistrationDiagnosis

http://www.intravenousimmunoglobulin.org/ 19

2. RegistrationIndication & Dose Information

http://www.intravenousimmunoglobulin.org/ 20

Patient Listing

http://www.intravenousimmunoglobulin.org/ 21

Agenda

• IVIg Introduction and Background

• Proposed Process Overview

• Database Login and Registration Demo

• Database Panel and Infusion Demo

• Database Follow Up Demo

• End User Support Options

• Questions

http://www.intravenousimmunoglobulin.org/ 22

3. PanelPanel Information

http://www.intravenousimmunoglobulin.org/ 23

4. InfusionPrescription Details

http://www.intravenousimmunoglobulin.org/ 24

4. InfusionPrescription Returns

http://www.intravenousimmunoglobulin.org/ 25

4. InfusionSummary

http://www.intravenousimmunoglobulin.org/ 26

Agenda

• IVIg Introduction and Background

• Proposed Process Overview

• Database Login and Registration Demo

• Database Panel and Infusion Demo

• Database Follow Up Demo

• End User Support Options

• Questions

http://www.intravenousimmunoglobulin.org/ 27

5. Follow-upFollow-up Details

http://www.intravenousimmunoglobulin.org/ 28

5. Follow-upUpdate Registration

http://www.intravenousimmunoglobulin.org/ 29

Patient Listing

http://www.intravenousimmunoglobulin.org/ 30

Agenda

• IVIg Introduction and Background

• Proposed Process Overview

• Database Login and Registration Demo

• Database Panel and Infusion Demo

• Database Follow Up Demo

• End User Support Options

• Questions

http://www.intravenousimmunoglobulin.org/ 31

There are a number of support options – try website first

Local Trust IT

Local Trust IT

DendriteDendrite

MDSASMDSAS

Database Users

Database Users

Lost / Forgotten Passwords? Local Internet Access Issues?

All other queries should be logged with MDSAS first

• Demand Management Plan and Clinical Guidelines

• Frequently Asked Questions for Programme and Database

• IVIg Database Detailed Reference Guide

• Link to the database and training materials

The website will contain:

http://www.intravenousimmunoglobulin.org/ 32

Agenda

• IVIg Introduction and Background

• Proposed Process Overview

• Database Login and Registration Demo

• Database Panel and Infusion Demo

• Database Follow Up Demo

• End User Support Options

• Questions

http://www.intravenousimmunoglobulin.org/ 33

Did we meet our Objectives?

• High level understanding of the need for the IVIg programme:– Address problems with supply of IVIg and Demand Management– Database to inform on IVIg usage and enable tracking and forecasting

• Identify the key stakeholders in the programme:– Department of Health sponsor and own the programme– NHS MDSAS will support the end user community

• Understand how to use the key functions of the database:

– Easy to use database as demonstrated– Training materials available on the internet

• Understand your role in updating the database:– Data entry and filling in the required forms

• Establish who will support you going forward and how to get help:– NHS MDSAS will support the end user community

• Answer your questions